Clinical Trials on Androgenetic Alopecia (AGA)

Total 2657 results

Momentum Data
Pfizer; University of Oxford

Active, not recruiting

Healthcare Disparities in Alopecia Areata

Alopecia Areata

United Kingdom
Jinnah Postgraduate Medical Centre

Completed

Efficacy of Oral Apremilast in the Treatment of Alopecia Areata at the Tertiary Care Hospital, Karachi.

Alopecia Areata

Pakistan
Concert Pharmaceuticals

Completed

Efficacy and Tolerability Study of Two Dosing Regimens of CTP-543 in Adults With Alopecia Areata

Alopecia Areata

United States, Canada
Reistone Biopharma Company Limited

Completed

A Phase II Study in Patients With Alopecia Areata

Alopecia Areata

China, Australia, United States
Janssen Research & Development, LLC

Withdrawn

A Study of JNJ-64304500 in Participants With Alopecia Areata

Alopecia Areata

United States, Japan, France, Australia
Alexandria University

Completed

Transepidermal Delivery of Triamcinolone Acetonide or Platelet Rich Plasma Using Either Fractional Carbon Dioxide Laser or Microneedling in Treatment of Alopecia Areata

Alopecia Areata

Egypt
Aclaris Therapeutics, Inc.

Terminated

A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata

Alopecia Areata

United States
Kasr El Aini Hospital

Unknown

Comparative Study for Treatment of Alopecia Areata Using Carboxytherapy and Intralesional Steroids

Alopecia Areata

Egypt
Centre Hospitalier Universitaire de Nice

Completed

TREg Activation in the Treatment of the PELADE (Alopecia Areata) (TreatPelade)

Alopecia Areata

France
Columbia University
Locks of Love; Alopecia Areata Initiative - Gates Foundation

Completed

Pilot Study to Evaluate the Efficacy of Ruxolitinib in Alopecia Areata

Alopecia Areata

United States
GlaxoSmithKline

Completed

AVODART® Alopecia Post-marketing Surveillance (PMS) (AVODART®PMS)

Alopecia

Korea, Republic of
Elena Pope
Dermatology Foundation

Terminated

Topical Garlic Concentrate for Alopecia Areata in Children

Alopecia Areata

Canada
University of British Columbia

Completed

Treatment of Alopecia Areata of the Scalp With Intradermal Injections of Botulinum Toxin

Alopecia Areata

Canada
University of Miami

Completed

Vytorin in the Treatment of Alopecia Areata

Alopecia Areata

United States
University of Minnesota

Completed

Response of Topical Capsaicin in Alopecia Areata

Alopecia Areata

United States
Johnson & Johnson Healthcare Products Division...

Completed

Clinical Trial in Females With Female Pattern Hair Loss

Alopecia

United States, United Kingdom, Canada, France, Germany
Siriraj Hospital

Unknown

The Comparison Study of Intralesional Botulinum Toxin A and Corticosteroid Injection for Alopecia Areata

Alopecia Areata

Thailand
Mitos Pharmaceuticals

Terminated

Safety and Preliminary Efficacy Study of MTS-01 for the Prevention of Alopecia Induced by WHole Brain Radiotherapy

Alopecia
Cooler Heads Care Inc.

Not yet recruiting

Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss

Breast Cancer | Alopecia | Chemotherapy-induced Alopecia | Hair Loss
Egymedicalpedia

Recruiting

Evaluation of Latanoprost Combined With Fractional Erbium- YAG Laser

Alopecia Areata

Egypt
Icahn School of Medicine at Mount Sinai

Not yet recruiting

Dupilumab in the Treatment of Pediatric Alopecia Areata (PEDAL)

Alopecia Areata

United States
ASLAN Pharmaceuticals

Recruiting

Investigate the Efficacy and Safety of Farudodstat Compared With Its Placebo in Adult Alopecia Areata Participants (FAST-AA)

Alopecia Areata

United States
Assiut University

Not yet recruiting

Topical Cetirizine in Treatment of Localized Alopecia Areata

Alopecia Areata
Assiut University

Not yet recruiting

Role of Minoxidil in Alopecia Areata Transepidermal Drug Delivery of Minoxidil Via Either Fractional Carbon Dioxide Laser or Microneedling Versus Its Topical Nanoparticles Preparation for Treatment of Alopecia Areata

Alopecia Areata
Emma Guttman
Regeneron Pharmaceuticals

Recruiting

Regeneron AA Multicenter (Dupilumab)

Alopecia Areata

United States
Sichuan Kelun Pharmaceutical Research Institute...

Not yet recruiting

A Study of KL130008 in Adults With Severe Alopecia Areata

Alopecia Areata

China
AnaptysBio, Inc.

Recruiting

A Study to Evaluate the Efficacy and Safety of Rosnilimab (ANB030) in Treatment of Subjects With Moderate-to-Severe Alopecia Areata (AZURE)

Alopecia Areata

United States
Assiut University

Not yet recruiting

Excimer Light and Topical Steroid in Treatment of Alopecia Areata

Alopecia Areata
Eli Lilly and Company
Incyte Corporation

Active, not recruiting

A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata (BRAVE-AA1)

Alopecia Areata

United States, Japan, Puerto Rico, Mexico, Korea, Republic of
Eurofarma Laboratorios S.A.

Active, not recruiting

Treatment of Androgenetic Alopecia in Men for 24 Weeks (MINOX)

Alopecia

Brazil
Q32 Bio Inc.
Innovaderm Research Inc.

Active, not recruiting

Randomized, Double-Blind, Placebo-Controlled Phase 2a, Proof-of-Concept Trial of ADX-914 Phase 2a Trial for the Treatment of Severe Alopecia Areata (SIGNAL-AA)

Alopecia Areata

United States
Concert Pharmaceuticals

Completed

A Study to Evaluate the Durability of Response Study of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata

Alopecia Areata

United States
Ornovi, Inc.

Withdrawn

A First in Human Single and Multiple Ascending Dose and Open Label Food Effect Study of OR-101 in Healthy Subjects

Alopecia Areata

Australia
Egymedicalpedia

Completed

Evaluation of the Effect of Topical Calcipotriol Versus Platelet-Rich Plasma

Alopecia Areata

Egypt
Pfizer
Arena is a wholly owned subsidiary of Pfizer

Completed

Safety and Efficacy of Oral Etrasimod in Adult Participants With Moderate-to-Severe Alopecia Areata

Alopecia Areata

United States, Canada
Concert Pharmaceuticals

Completed

Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA2) (THRIVE-AA2)

Alopecia Areata

Spain, United States, Poland, Canada, France, Germany, Hungary
Concert Pharmaceuticals

Completed

Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA1) (THRIVE-AA1)

Alopecia Areata

United States, Canada, Poland, France, Spain
Yale University

Completed

Follicular Revival in Treatment-resistant Alopecia Areata: Evaluating Use of Micro-needling

Alopecia Areata

United States
Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Completed

Study to Evaluate the Safety and Efficacy ofJaktinib Hydrochloride Tablets in Severe Alopecia Areata

Alopecia Areata

China
Bioithas SL
Bionou Research, S.L.

Completed

Clinical Trial to Evaluate Effectiveness of a Probiotic Preparation Administered to Patients With Alopecia Areata

Alopecia Areata

Spain
Centre Hospitalier Universitaire de Nice

Terminated

Evaluation of the Efficacy and Tolerability of Treatment With Interleukin-2 in Severe and Resistant Alopecia Areata (IL2)

Alopecia Areata

France
Tufts Medical Center
Pfizer

Withdrawn

Topical Crisaborole in Patients With Alopecia Areata

Alopecia Areata

United States
Icahn School of Medicine at Mount Sinai
Novartis

Terminated

A Study of Secukinumab for the Treatment of Alopecia Areata

Alopecia Areata

United States
University of Minnesota

Completed

Combined Restylane and Triamcinolone Acetonide Injections for the Treatment of Alopecia Areata

Alopecia Areata

United States
Legacy Healthcare SA

Completed

Efficacy, Safety and Tolerability of CG428 Cutaneous Solution on Chemotherapy Induced Alopecia; Controlled Study (ELAN) (ELAN)

Alopecia

Switzerland
Columbia University
University of Minnesota

Terminated

Intralesional Steroids in the Treatment of Alopecia Areata

Alopecia Areata

United States
Columbia University
Locks of Love

Completed

Study To Evaluate The Efficacy Of Tofacitinib In Moderate To Severe Alopecia Areata, Totalis And Universalis

Alopecia Areata

United States
Allergan

Completed

A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males

Alopecia

United States
Aswan University Hospital

Completed

Topical Calcipotriol Versus Narrowband Ultraviolet B in Treatment of Alopecia Areata

Alopecia Areata

Egypt
GlaxoSmithKline

Completed

A Study To Assess The Efficacy And Safety Of Dutasteride 0.5mg Once Daily For 6 Months In The Treatment Of Male Subjects With Androgenetic Alopecia

Alopecia

3

Subscribe